BAT to Establish Smokeless Product Production Center in Pécs, Hungary

BAT by 2FIRSTS.ai
Apr.23.2024
BAT to Establish Smokeless Product Production Center in Pécs, Hungary
British American Tobacco plans to establish a smokeless product production center in Pécs, Hungary, creating 450 new jobs.

According to Hungarian media Infostart, on April 19, Hungarian Foreign Minister Péter Szijjártó announced that British American Tobacco plans to establish a smokeless product production center in the Hungarian city of Pécs. He stated that this investment will create 450 new job opportunities, estimated at 60 billion Hungarian forints (160 million USD), and will make Pécs one of the largest disposable investments in the country's history.

 

The project will also help achieve two major economic policy goals in Hungary. Firstly, as an export-oriented country, Hungary's economy heavily relies on exports, with over 80% of products produced here being sold in foreign markets. Secondly, British American Tobacco is the seventh largest investor in Hungary, providing 50,000 job opportunities for locals. According to the minister, Hungary's bilateral trade volume is expected to reach 6.5 billion euros (6.928 billion USD) by 2023.

 

The Regional Director for British American Tobacco in Europe, Usman Zahur, pointed out that the Pace factory could become one of the world's major production centers for smoke-free alternative products.

 

This significant investment will further enhance our long-term strategic focus on Hungary. By 2035, new product categories will account for 50% of our revenue. The production capacity of the new factories, particularly the Pécs facility, is crucial for us to achieve this goal.

 

British American Tobacco stated in a press release:

 

The new manufacturing center mainly produces nicotine pouches and herbal heating sticks, supplying the Hungarian and global markets.

 

The company will add 16 new production lines and also plans to build a new 7,500-square-meter manufacturing plant. In addition, smokeless tobacco and herbal heating sticks will be introduced as new product categories in the company's lineup.

 

The statement claims that British American Tobacco achieved sales revenue of £27.28 billion (US $33.7 billion) and adjusted operating profit of £12.46 billion (US $15.3 billion) globally in 2023, and employed over 46,000 staff.

 

British American Tobacco's subsidiary in Hungary, BAT Pécsi Dohánygyár Kft. (BAT PD Kft.), is the largest investor in the tobacco industry in Hungary, employing over 900 workers in its facilities located in Budapest and Pécs.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris Japan Unveils TEREA “Blossom Pearl” for IQOS ILUMA
Philip Morris Japan Unveils TEREA “Blossom Pearl” for IQOS ILUMA
Philip Morris Japan announced that it will launch “TEREA Blossom Pearl,” a new tobacco stick for IQOS ILUMA, on May 11. The new product will expand the TEREA lineup to 27 variants. It features a capsule menthol flavor with strawberry and subtle herbal notes and is priced at JPY 620, or about USD 4.14 based on an assumed rate of 1 JPY = 0.00668 USD. The exchange-rate source should be verified and added.
Apr.28 by 2FIRSTS.ai
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
2Firsts Exclusive Analysis | RLX Q1 Revenue Rises 96.2%, International Business Points to a More Integrated Global Strategy
RLX Technology’s Q1 net revenues rose 96.2% year over year, with international business accounting for 72.3% of total revenue. Beyond the headline growth, the results point to deeper globalization: European operations, Nexus supply-chain integration and a broader product portfolio are becoming key signals to watch.
Special Report
May.20
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
Revised Tobacco Business Act to Take Effect in South Korea, Banning Online Sales of Liquid Vapes
South Korea’s Ministry of Health and Welfare will implement a partial revision of the Tobacco Business Act on April 24. The scope will expand from products made with “tobacco leaves” to all products manufactured with natural or synthetic nicotine. Synthetic nicotine liquid e-cigarettes, which had previously been treated as industrial products and were freely sold and advertised online, will from April 24 be subject to the same regulations as ordinary tobacco products.
Apr.23 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai